People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vantix Diagnostics, Inc. | — | Biotechnology | Series B | $22.6M | $178.8M | 2012 |
Richard A. Rappaport at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard A. Rappaport on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| DOUG ARMSTRONG | 1 | 2 |
| Steve Lufkin | 1 | 1 |
| Richard Wardle | 1 | 1 |
| Anthony Pintsopoulos | 1 | 1 |
| Richard Rappaport | 1 | 1 |
| Douglas Armstrong | 1 | 1 |
| Anthony C. Pintsopoulos | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.